发明名称 |
GLP-1 AND METHODS FOR TREATING DIABETES. |
摘要 |
<p>The present invention relates to use of GLP-1 or a related molecule having GLP-effect for the manufacture of a medicament for preventing or treating diabetes in a mammal. The amount and timing of administration of said medicament are subsequently reduced to produce a "drug holiday". Practice of the invention achieves effective therapy without continuous drug exposure and without continuous presence of therapeutic levels of the drug. The invention also discloses a method of treating diabetes and related disorders in a mammal by administering glucagon like peptide (GLP-1) or a related molecule having GLP-1 like effect and thereby providing a therapeutically effective amount of endogenous insulin.</p> |
申请公布号 |
MXPA04012497(A) |
申请公布日期 |
2005.07.14 |
申请号 |
MX2004PA12497 |
申请日期 |
2003.07.02 |
申请人 |
ZEALAND PHARMA A/S |
发明人 |
EVA STEINESS |
分类号 |
A61K38/22;A61K38/26;A61K38/28;A61K38/31;A61P3/10;(IPC1-7):A61K38/26;A61K47/48;C07K14/575;C07K14/605;C12N5/06 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|